LEN vs OGEN
LEN (LEN) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
LEN does not have a complete income-statement cache yet.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
LEN currently screens at market cap $0. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the LEN and OGEN stock pages for the full models.
Not investment advice.